Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 101
- −11 vs. Q1 2025
- Portfolio value
- $382.5M
- −$23.0M (−5.7%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,620,990 | $27.2M | 7.1% | +48,809+3.1% | Added | History |
| NVMINova Ltd. | COM | 75,836 | $20.9M | 5.5% | −14,861−16.4% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,571,564 | $14.7M | 3.8% | −92,410−5.6% | Reduced | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 264,722 | $11.5M | 3.0% | +203,173+330.1% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 326,718 | $10.8M | 2.8% | +181,757+125.4% | Added | History |
| SNYSanofi | SPONSORED ADR | 219,515 | $10.6M | 2.8% | −85,000−27.9% | Reduced | History |
| BIIBBiogen Inc. | COM | 82,738 | $10.4M | 2.7% | +60,000+263.9% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 135,060 | $9.44M | 2.5% | −40,000−22.8% | Reduced | History |
| LLYEli Lilly & Co | Stock | 11,540 | $9.00M | 2.4% | −150−1.3% | Reduced | History |
| NVDANVIDIA Corp | Stock | 54,515 | $8.61M | 2.3% | +24,910+84.1% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 419,540 | $8.54M | 2.2% | −88,289−17.4% | Reduced | History |
| NVONovo Nordisk A S | ADR | 105,677 | $7.29M | 1.9% | −12,403−10.5% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 32,441 | $7.12M | 1.9% | −4,166−11.4% | Reduced | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 138,001 | $6.72M | 1.8% | +120,873+705.7% | Added | History |
| ORAOrmat Technologies, Inc. | COM | 78,000 | $6.53M | 1.7% | −6,000−7.1% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 480,974 | $6.51M | 1.7% | +15,448+3.3% | Added | History |
| FBRXForte Biosciences, Inc. | COM NEW | 495,109 | $6.40M | 1.7% | +495,109 | New | History |
| METAMeta Platforms, Inc. | Stock | 8,526 | $6.29M | 1.6% | −1,436−14.4% | Reduced | History |
| JNJJohnson & Johnson | Stock | 40,831 | $6.24M | 1.6% | −12,000−22.7% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 11,792 | $5.87M | 1.5% | +7,200+156.8% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 990,718 | $5.68M | 1.5% | +990,718 | New | History |
| Ormat Technologies, Inc.686688AC6 | DEBT 2.500% 7/1 | 5,037,000 | $5.61M | 1.5% | 00.0% | Unchanged | – |
| PHVSPharvaris N.V. | COM | 309,931 | $5.45M | 1.4% | −73,925−19.3% | Reduced | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,959,610 | $5.31M | 1.4% | −347,509−15.1% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 335,333 | $4.96M | 1.3% | +135,333+67.7% | Added | History |
| ABBVAbbVie Inc. | Stock | 25,256 | $4.69M | 1.2% | −5,000−16.5% | Reduced | History |
| GSKGSK plc | ADR | 122,000 | $4.68M | 1.2% | −8,000−6.2% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 109,757 | $4.62M | 1.2% | −30,903−22.0% | Reduced | History |
| NVSNovartis AG | ADR | 37,000 | $4.48M | 1.2% | −13,000−26.0% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 799,957 | $4.38M | 1.1% | +799,957 | New | History |
| MAZEMaze Therapeutics, Inc. | COM | 356,453 | $4.37M | 1.1% | +899+0.3% | Added | History |
| ANNXAnnexon, Inc. | COM | 1,764,387 | $4.23M | 1.1% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 256,743 | $4.11M | 1.1% | +62,105+31.9% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 394,693 | $4.01M | 1.0% | +159,859+68.1% | Added | History |
| MRKMerck & Co., Inc. | Stock | 48,600 | $3.85M | 1.0% | −11,000−18.5% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 174,900 | $3.77M | 1.0% | +174,900 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 87,108 | $3.76M | 1.0% | −279,500−76.2% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 100,085 | $3.64M | 1.0% | −167,300−62.6% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 126,000 | $3.58M | 0.9% | +20,000+18.9% | Added | – |
| ACOGAlpha Cognition Inc. | COM NEW | 376,649 | $3.51M | 0.9% | −220,343−36.9% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 751,447 | $3.35M | 0.9% | −330,000−30.5% | Reduced | History |
| HELPCybin Inc. | COM NEW | 398,309 | $3.34M | 0.9% | −128,913−24.5% | Reduced | History |
| AMATApplied Materials Inc | Stock | 18,000 | $3.30M | 0.9% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 202,996 | $3.21M | 0.8% | −74,554−26.9% | Reduced | History |
| IMTXImmatics N.V. | SHS | 583,105 | $3.14M | 0.8% | −338,006−36.7% | Reduced | History |
| SVRASavara Inc | COM | 1,310,233 | $2.99M | 0.8% | +26,082+2.0% | Added | History |
| UBERUber Technologies, Inc | Stock | 30,000 | $2.80M | 0.7% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 159,323 | $2.72M | 0.7% | +1,392+0.9% | Added | History |
| CAMTCamtek Ltd | ORD | 31,976 | $2.70M | 0.7% | +8,890+38.5% | Added | History |
| ESLTElbit Systems Ltd | Stock | 6,000 | $2.70M | 0.7% | +6,000 | New | History |
| PANWPalo Alto Networks Inc | Stock | 13,114 | $2.68M | 0.7% | +13,114 | New | History |
| WIXWix.com Ltd. | SHS | 16,931 | $2.68M | 0.7% | +8,131+92.4% | Added | History |
| AMGNAmgen Inc | Stock | 9,500 | $2.65M | 0.7% | −500−5.0% | Reduced | History |
| SEDGSolaredge Technologies, Inc. | COM | 127,966 | $2.61M | 0.7% | −181,250−58.6% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 128,515 | $2.58M | 0.7% | +16,772+15.0% | Added | History |
| SKYESkye Bioscience, Inc. | COM NEW | 538,434 | $2.25M | 0.6% | −937,919−63.5% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 221,416 | $2.11M | 0.6% | −107,846−32.8% | Reduced | History |
| PFEPfizer Inc | Stock | 86,000 | $2.08M | 0.5% | −4,000−4.4% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 145,372 | $2.05M | 0.5% | +45,588+45.7% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 57,497 | $2.04M | 0.5% | −20,696−26.5% | Reduced | History |
| ETNB89bio, Inc. | COM | 205,675 | $2.02M | 0.5% | −412,668−66.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 95,931 | $1.99M | 0.5% | +11,931+14.2% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 85,840 | $1.98M | 0.5% | −40,000−31.8% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 114,346 | $1.98M | 0.5% | −67,000−36.9% | Reduced | History |
| CRMSalesforce, Inc. | Stock | 6,800 | $1.85M | 0.5% | −2,300−25.3% | Reduced | History |
| ENGNenGene Therapeutics Inc. | COM | 504,409 | $1.84M | 0.5% | −23,956−4.5% | Reduced | History |
| Cyberark Software LtdM2682V108 | SHS | 4,000 | $1.63M | 0.4% | +4,000 | New | – |
| MRVLMarvell Technology, Inc. | COM | 18,730 | $1.45M | 0.4% | +3,660+24.3% | Added | History |
| ATXSAstria Therapeutics, Inc. | COM | 257,402 | $1.38M | 0.4% | +67,602+35.6% | Added | History |
| KURAKura Oncology, Inc. | COM | 235,522 | $1.36M | 0.4% | −108,000−31.4% | Reduced | History |
| IBITiShares Bitcoin Trust ETF | ETF | 21,455 | $1.31M | 0.3% | +13,305+163.3% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 128,780 | $1.21M | 0.3% | −252,300−66.2% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 555,814 | $1.19M | 0.3% | −456,935−45.1% | Reduced | History |
| AMDAdvanced Micro Devices Inc | Stock | 8,250 | $1.17M | 0.3% | +8,250 | New | History |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 717,518 | $1.16M | 0.3% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 175,371 | $1.14M | 0.3% | −159,616−47.6% | Reduced | History |
| CEVACeva Inc | COM | 48,920 | $1.08M | 0.3% | 00.0% | Unchanged | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 310,343 | $1.07M | 0.3% | −149,904−32.6% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 143,693 | $1.03M | 0.3% | −191,331−57.1% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 7,335 | $1.01M | 0.3% | +7,335 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 420,000 | $970.2K | 0.3% | +420,000 | New | History |
| PMNProMIS Neurosciences Inc. | COM | 1,899,297 | $918.9K | 0.2% | −30,000−1.6% | Reduced | History |
| VTGNVistagen Therapeutics, Inc. | COM | 447,939 | $895.9K | 0.2% | −342,611−43.3% | Reduced | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 738,048 | $856.1K | 0.2% | −162,380−18.0% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 17,500 | $810.1K | 0.2% | −2,500−12.5% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 183,094 | $732.4K | 0.2% | −22,765−11.1% | Reduced | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $683.2K | 0.2% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM NEW | 163,307 | $677.7K | 0.2% | +163,307 | New | History |
| BCAXBicara Therapeutics Inc. | COM | 65,679 | $610.2K | 0.2% | +65,679 | New | History |
| LRMRLarimar Therapeutics, Inc. | COM | 196,635 | $568.3K | 0.1% | −169,669−46.3% | Reduced | History |
| SSentinelOne, Inc. | CL A | 27,000 | $493.6K | 0.1% | +27,000 | New | History |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $456.3K | 0.1% | 00.0% | Unchanged | History |
| CGNTCognyte Software Ltd. | ORD SHS | 45,181 | $417.5K | 0.1% | +45,181 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 58,539 | $268.1K | 0.1% | −49,934−46.0% | Reduced | History |
| CLYMClimb Bio, Inc. | COM | 209,837 | $260.2K | 0.1% | −32,098−13.3% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM NEW | 50,190 | $244.4K | 0.1% | +50,190 | New | History |
| PEPGPepGen Inc. | COM | 156,467 | $173.7K | <0.1% | +156,467 | New | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 60,454 | $144.5K | <0.1% | −20,000−24.9% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 328,562 | $120.6K | <0.1% | −30,000−8.4% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 14,671 | $81.4K | <0.1% | −107,346−88.0% | Reduced | History |
Options (9)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $16.6M | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | – | $6.57M |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | – | $5.90M |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | – | $4.21M |
| iShares Tr464287432 | 20 YR TR BD ETF | – | $4.15M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $2.56M |
| BBIOBridgeBio Pharma, Inc. | COM | $2.15M | – |
| COGTCogent Biosciences, Inc. | COM | – | $1.44M |
| ELDNEledon Pharmaceuticals, Inc. | COM | – | $84.6K |
Sold out since Q1 2025 (27)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| NICENICE Ltd. | SPONSORED ADR | 33,303 | $5.13M | 1.3% | History |
| MRUSMerus N.V. | COM | 106,532 | $4.48M | 1.1% | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,604,429 | $2.86M | 0.7% | History |
| WDAYWorkday, Inc. | CL A | 10,000 | $2.34M | 0.6% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 52,009 | $2.30M | 0.6% | History |
| GOOGAlphabet Inc. | Stock | 13,500 | $2.11M | 0.5% | History |
| VKTXViking Therapeutics, Inc. | COM | 83,270 | $2.01M | 0.5% | History |
| AVGOBroadcom Inc. | Stock | 11,695 | $1.96M | 0.5% | History |
| IONSIonis Pharmaceuticals Inc | COM | 63,821 | $1.93M | 0.5% | History |
| NKENIKE, Inc. | Stock | 30,050 | $1.91M | 0.5% | History |
| CHKPCheck Point Software Technologies Ltd | ORD | 8,334 | $1.90M | 0.5% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 271,792 | $1.81M | 0.4% | History |
| NTRNutrien Ltd. | COM | 30,894 | $1.53M | 0.4% | History |
| FROGJFrog Ltd | Stock | 42,871 | $1.37M | 0.3% | History |
| SHL Telemedicine Ltd78423T200 | ADS | 632,456 | $1.31M | 0.3% | – |
| INZYInozyme Pharma, Inc. | COM | 1,191,140 | $1.08M | 0.3% | History |
| OTLKOutlook Therapeutics, Inc. | Stock | 857,142 | $1.05M | 0.3% | History |
| ARVNArvinas, Inc. | COM | 125,000 | $877.5K | 0.2% | History |
| XENEXenon Pharmaceuticals Inc. | COM | 26,097 | $875.6K | 0.2% | History |
| PERIPerion Network Ltd. | SHS NEW | 102,612 | $835.3K | 0.2% | History |
| RGLSRegulus Therapeutics Inc. | COM | 452,845 | $792.5K | 0.2% | History |
| VIRVir Biotechnology, Inc. | COM | 90,855 | $588.7K | 0.1% | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 421,229 | $543.4K | 0.1% | History |
| FATEFate Therapeutics Inc | COM | 397,177 | $313.8K | 0.1% | History |
| ALECAlector, Inc. | COM | 109,208 | $134.3K | <0.1% | History |
| LVTXLAVA Therapeutics NV | SHS | 48,420 | $61.5K | <0.1% | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 100,000 | $1.58K | <0.1% | – |